Fortress Biotech (FBIO) Tops Q2 EPS by 16c

Fortress Biotech (NASDAQ: FBIO) reported Q2 EPS of ($0.07), $0.16 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $17.39 million versus the consensus estimate of $15.46 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform